Director/PDMR Shareholding

RNS Number : 0349Y

GlaxoSmithKline PLC

23 February 2012

 



Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of a Director and Persons Discharging Managerial Responsibility (PDMR) in the Ordinary shares of GlaxoSmithKline plc arising from the sale of Ordinary shares at a price of £14.05 per Ordinary share on 20 February 2012 to meet tax liabilities following the vesting of awards granted under the GlaxoSmithKline 2009 Performance Share Plan (PSP).

	Number of Ordinary shares sold to meet tax liabilities following the vesting of a PSP award
Sir Andrew Witty*	135,842
Mr S M Bicknell	6,132
Mr J M Clarke	22,217
Mr M Dunoyer	2,951
Mr E Gray	14,427
Mr D S Redfern	8,368
Ms C Thomas	11,397
Mr P Thomson	318
Mr P Vallance	10,939
Mrs V Whyte	318

* Denotes an Executive Director

The table below sets out changes in the interests of a Director and PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc on 22 February 2012 arising from the withholding of ADSs at a price of $44.88 per ADS, the closing price on 17 February 2012, to meet tax liabilities following the vesting of awards granted under the PSP.

	Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award
Dr M Slaoui*	15,159
Ms D Connelly	14,317
Mr W C Louv	4,510
Dr D Pulman	6,945
Mr D Troy	11,637

* Denotes an Executive Director

The Company, Directors and PDMRs were advised of these transactions on 23 February 2012.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

23 February 2012

 

END

 

 

RDSDXLFLLLFZBBK